Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Mucosal Immunology|April 8, 2018
Aryl hydrocarbon receptor and intestinal immunityBruno Lamas, Jane M Natividad, Harry SokolNutrients|October 8, 2020
Blends of Human Milk Oligosaccharides Confer Intestinal Epithelial Barrier Protection in VitroJane M Natividad, Andreas Rytz, Sonia Keddani, et al.Human Vaccines & Immunotherapeutics|April 16, 2014
Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammationRebeca Martín, Florian Chain, Sylvie Miquel, et al.Plos One|August 4, 2009
Host responses to intestinal microbial antigens in gluten-sensitive miceJane M Natividad, Xianxi Huang, Emma Slack, et al.BMC Microbiology|April 19, 2015
Faecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine modelRebeca Martín, Sylvie Miquel, Florian Chain, et al.Inflammatory Bowel Diseases|June 11, 2015
Ecobiotherapy Rich in Firmicutes Decreases Susceptibility to Colitis in a Humanized Gnotobiotic Mouse ModelJane M Natividad, Maria I Pinto-Sanchez, Heather J Galipeau, et al.Nature Communications|July 20, 2018
Bilophila wadsworthia aggravates high fat diet induced metabolic dysfunctions in miceJane M Natividad, Bruno Lamas, Hang Phuong Pham, et al.Gut|August 10, 2017
Card9 mediates susceptibility to intestinal pathogens through microbiota modulation and control of bacterial virulenceBruno Lamas, Marie-Laure Michel, Nadine Waldschmitt, et al.The American Journal of Gastroenterology|April 9, 2014
Novel role of the serine protease inhibitor elafin in gluten-related disordersHeather J Galipeau, Michelle Wiepjes, Jean-Paul Motta, et al.Nature Medicine|May 10, 2016
CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligandsBruno Lamas, Mathias L Richard, Valentin Leducq, et al.Pageof 2